Onto Innovation Reports Record Revenue, Secures $240M+ HBM Contract, and Ships Next-Gen Dragonfly
summarizeSummary
Onto Innovation reported record Q4 and full-year revenue, alongside a significant $240M+ volume purchase agreement for HBM manufacturing and shipments of its next-generation Dragonfly® systems, despite a decline in GAAP profitability.
check_boxKey Events
-
Record Revenue Achieved
The company reported record quarterly revenue of $267 million for Q4 2025 and record full-year revenue of $1.005 billion for 2025.
-
Secures Major HBM Contract
Onto Innovation closed a new volume purchase agreement estimated at over $240 million with a leading high bandwidth memory (HBM) manufacturer, supporting expansion plans through 2027.
-
Next-Gen Product Shipments
Next-generation Dragonfly® systems for high resolution 2D applications were shipped to multiple customers, with evaluation periods currently underway.
-
Acquisition Completed
The acquisition of key product lines from the materials analysis business of Semilab International was successfully completed.
auto_awesomeAnalysis
Onto Innovation reported record quarterly and full-year revenue for 2025, signaling continued top-line growth. While GAAP profitability metrics saw a notable decline, the company highlighted significant forward-looking business developments. The most impactful is a substantial volume purchase agreement exceeding $240 million with a leading high bandwidth memory (HBM) manufacturer, underscoring strong demand in the AI sector. Additionally, the shipment of next-generation Dragonfly® systems for customer evaluation and the completion of the Semilab acquisition position the company for future growth. Investors will likely weigh the current GAAP profit compression against the strong strategic wins and positive outlook for the semiconductor capital equipment market, particularly in AI-driven segments.
At the time of this filing, ONTO was trading at $223.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $11B. The 52-week trading range was $85.88 to $229.87. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.